This should further reduce risk in certain aspects? the fact that it has use in approved products shown to be effective against inflamation.
'Budesonide is an anti-inflammatory corticosteroid that is the active pharmaceutical ingredient in several products approved by the U.S. Food and Drug Administration (FDA), including products for the treatment of pediatric asthma, allergic rhinitis and Crohn's disease.'
It's about to roll down a big hill of year end selling.
If you like this stock, wait till AFTER 1st week of January to open or add to your position. By then, year end seller will have sold and those with big gains for the year will have sold after 1/1 thus pushing their gain onto 2012's tax return.